A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 283, Issue 1 27-1, 2002, Pages

  Matsuoka, Hiroto ^a   Arai, Toru ^a   Mori, Masahide ^b   Goya, Sho ^b   Kida, Hiroshi ^a   Morishita, Hiroshi ^a,b   Fujiwara, Hiroshi ^a   Tachibana, Isao ^a   Osaki, Tadashi ^a   Hayashi, Seiji ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Anti apoptotic effect; Phosphorylation of p38 mitogen activated protein kinase; Tumor necrosis factor ; connective tissue growth factor

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; BLEOMYCIN; CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CACHEXIA; CONTROLLED STUDY; HISTOPATHOLOGY; LUNG ALVEOLUS CELL; LUNG FIBROSIS; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0036310801     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00187.2001     Document Type: Article

References (59)

1. Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo
2. The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells
3. Simple method of estimating severity of pulmonary fibrosis on a numerical scale
4. Tumor necrosis factor alpha (TNF alpha) and transforming growth factor beta 1 (TGF beta 1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts
5. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor
6. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis
7. Transforming growth factor beta in tissue fibrosis
8. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis
9. β-adrenergic activation of p38 MAP kinase in adipocytes
10. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway
11. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: Down-regulation by cAMP
12. Effects of aging on antibacterial mechanisms in experimental pneumonia
13. Influence of FR-167653, an inhibitor of TNF-alpha and IL-1, on the cardiovascular response to chronic infusion of lipopolysaccharide in conscious rats
14. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice
15. Tumor necrosis factor: Immunologic, antitumor, metabolic, and cardiovascular activities
16. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen
17. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice
18. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells
19. Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor necrosis factor alpha gene expression in T lymphocytes
20. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair
21. CREB is activated by UVC through a p38/HOG-1-dependent protein kinase
22. Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases
23. The effects of FR-167653 on pulmonary ischemiareperfusion injury in dogs
24. Comparison of suppressive effects of a new anti-inflammatory compound, FR-167653, on production of PGE2 and inflammatory cytokines, human monocytes, and alveolar macrophages in response to endotoxin
25. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis
26. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis
27. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8
28. Trans-acting regulatory factors for T cell antigen receptor α- and γ-chain gene expression
29. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis
30. 2
31. The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis
32. IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases
33. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice
34. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis
35. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice
36. Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice
37. Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and -independent mechanisms
38. Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor-alpha
39. Tumor necrosis factor/cachectin plays a key role in bleomycininduced pneumopathy and fibrosis
40. Interleukin 1 receptor antagonist (IL-lra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica
41. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine
42. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins
43. Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha) mRNA induction. Evidence for selective destabilization of TNF-alpha transcripts
44. Changes in pulmonary histology and exfoliated bronchoalveolar cells induced by in vivo introduction of the tumor necrosis factor-alpha gene
45. Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta 1 and myofibroblasts
46. Induction of tumor necrosis factor-alpha as a cause of bleomycin-related toxicity
47. FR-167653, a p38 mitogen-activated protein kinase inhibitor, prevents Helicobacter pylori-induced gastritis in Mongolian gerbils
48. Inhibitory effects of a lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis in mice
49. A new anti-inflammatory compound, FR-167653, ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats
50. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid
51. Effect of FR-167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation
52. FR-167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-alpha, ameliorates endotoxin-induced shock
53. A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat
54. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36
55. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney
56. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor β1, or platelet-derived growth factor B gene
57. 2-terminal kinase
58. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure
59. A preliminary study of long-term treatment with interferon gamma-lb and low-dose prednisolone in patients with idiopathic pulmonary fibrosis